RxDoctor Payments Data

Christopher Guzik, DO

Family Medicine · Clermont, FLNPI 1396762126

Payments from drug & device makers

$1,961in general payments, 2019–2025

Across 100 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$264
  • Novo Nordisk$256
  • Amgen$190
  • GSK$157
  • Antares Pharma, Inc.$97
  • AstraZeneca$89
  • plus $909 from 22 others

What the payments were for

  • Food & beverage$1,92298%
  • Education$392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,961 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$167,284
Medicare patients
316
Services billed
1,732

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban59$67,487
OzempicSemaglutide27$32,621
MounjaroTirzepatide29$32,462
JardianceEmpagliflozin23$27,626
ArexvyRsvpref3 Antigen/As01e/Pf59$18,880
XareltoRivaroxaban16$13,014
LinzessLinaclotide14$9,294
Xtampza ErOxycodone Myristate13$8,914
ShingrixVaricella-Zoster Ge/As01b/Pf38$8,533
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen279$5,020
Levothyroxine Sodium343$4,645
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen65$4,578
Rosuvastatin Calcium294$4,541
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$3,333
SynthroidLevothyroxine Sodium30$3,196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$75$67,48759 claims
Novo NordiskOzempic$256$32,62127 claims
Lilly USA, LLCMounjaro$264$32,46229 claims
Boehringer IngelheimJardiance$51$27,62623 claims
GSKArexvy, Shingrix$157$27,41497 claims
AbbVieLinzess, Synthroid$41$12,49044 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Clermont

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →